Top Markets
Coin of the day
Pharmosa Biopharm Inc. Pharmosa Biopharm Inc.

Pharmosa Biopharm Inc.

6875
Rank in Stocks #20403
Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in... Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in the development of pharmaceutical products. Its current pipeline includes two key candidates: L606 and L608. L606 is an investigational inhalation/device combination therapy designed to treat both pulmonary arterial hypertension and pulmonary hypertension linked to interstitial lung disease. Similarly, L608 is another inhalation-based therapy, paired with a device, aimed at addressing pulmonary vascular disease. The company, which was established in 2000, originally operated under the name Pharmosa Limited before adopting its current name, Pharmosa Biopharm Inc., in October 2016. Its main offices are located in Taipei City, Taiwan.
Share Price
$1.02
Market Cap
$131.45M
Change (1 day)
-0.62%
Change (1 year)
-37.92%
Country
TW
Trade Pharmosa Biopharm Inc. (6875)

Category

P/B ratio for Pharmosa Biopharm Inc. (6875)
P/B ratio as of 2026 TTM: 0
According to Pharmosa Biopharm Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Pharmosa Biopharm Inc. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.3419 -
US
6.2413 -
NL
3.7087 -
US
2.5054 -
AU
- -
CH